-+ 0.00%
-+ 0.00%
-+ 0.00%

LEONABIO INC - EXPECTS PHASE 3 LASOFOXIFENE TRIAL ENROLLMENT COMPLETION IN 4Q 2026, TOPLINE DATA IN 2H 2027

Reuters·03/26/2026 21:10:00

Please log in to view news